Susceptibility Pattern, Genotyping, and Mutations of Klebsiella pneumoniae at Dr. H. Abdul Moeloek General Hospital

Authors

  • Hidayat Hidayat Department of Clinical Pathology, Faculty of Medicine, Malahayati University, Lampung
  • Ida Parwati Department of Clinical Pathology, Faculty of Medicine, Padjadjaran University, Bandung
  • Eko Agus Srianto Disease Investigation Center, Bandar Lampung, Lampung

DOI:

https://doi.org/10.24293/ijcpml.v30i3.2206

Keywords:

Klebsiella pneumoniae, susceptibility pattern, genotyping, mutations

Abstract

Klebsiella pneumoniae is one of the most common causes of severe hospital-acquired infection. ESBL-producing Klebsiella pneumoniae causes a major problem for clinical management and epidemiological study. The other factor identified was OmpK35 which is often poorly or not expressed and it can be altered by factors such as point mutations. This study aimed to determine the susceptibility pattern, and the genotyping and to investigate the mutations in OmpK35 of Klebsiella.pneumoniae. This is a cross-sectional study using susceptibility pattern data from the ninety isolates of Klebsiella pneumoniae from the patients admitted to Dr. H. Abdul Moeloek General Hospital, Lampung. The Genotype of ESBL genes and OmpK35 gene were determined by polymerase chain reaction and sequencing for identification of the mutation. The susceptibility rate of Klebsiella pneumoniae belonged to Ampicillin was 0%. The susceptibility rate belonged to Amikacin (96.6%), Meropenem (94.4%), and Ertapenem (94.4%).  From 90 isolates, the genotype blaSHV was found in 86.7%, and most of the isolates had OmpK35 genes (91.2%). Among the thirty isolates, 20% harbored mutations in the OmpK35 protein with substitution mutations. This finding indicated a high prevalence of antibiotic resistance, a high prevalence rate of ESBL gene production, and a high frequency of porin mutations among Klebsiella pneumoniae isolates.

Downloads

Download data is not yet available.

References

Venezia NS, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: A major worldwide source and shuttle for antibiotic resistance. FEMS Microbiology Reviews, 2017; 41(3): 252–275.

Aljeldah MM. Antimicrobial resistance and its spread is a global threat. Antibiotics, 2022; 11: 1082.

Martin RM, Bachman MA. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol, 2018; 8: 4.

Palmieri M, D’Andrea MM, Pelegrin AC, Mirande C, Brkic S, et al. Genomic epidemiology of Carbapenem- and colistin-resistant Klebsiella pneumoniae isolates from Serbia: Predominance of ST101 strains carrying a novel OXA-48 plasmid. Front Microbiol, 2020; 11: 294.

R Hymavathi, Kumari SS, Swarnalatha G, Surekha A. Prevalence of ESBL producing Klebsiella isolated from respiratory samples at intensive care units. Annual of International Medical and Dental Research, 2018; 4(4): 6-10.

Habibi H, Ahani Azhari A, Danesh A. Incidence of beta-lactamase enzymes among Klebsiella pneumoniae isolates causing urinary tract infections in Aliabad, North-East Iran. Infection Epidemiology and Microbiology, 2020; 6(3): 193-200.

Siriphap A, Kitti T, Khuekankaew A, Boonlao C, Thephinlap C, et al. High prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates: A 5-year retrospective study at a tertiary hospital in Northern Thailand. Front Cell Infect Microbiol, 2022; 12: 955774.

Sinanjung K, Nirwati H, Tholib Aman H. Extended Spectrum Beta Lactamase (ESBL)-producing Klebsiella pneumoniae clinical isolates and its susceptibility pattern to antibiotics at Dr. Soeradji Tirtonegoro General Hospital Klaten, Central Java. Gadjah Mada of Journal Medical Sciences, 2020; 52(1): 17-27.

Kim YT, Tae UK, Hyung SB. Characterization of extended-spectrum B-lactamase genotype TEM, SHV, and CTX-M producing Klebsiella pneumoniae isolated from clinical specimens in Korea. J Microbiol Biotechnol, 2006; 16(6): 889–895.

Zhang F, Cheng W. The mechanism of bacterial resistance and potential bacteriostatic strategies. Antibiotics, 2022; 11: 1215.

Paczosa MK, Mecsas J. Klebsiella pneumoniae: Going on the offense with a strong defense. Microbiology and Molecular Biology Reviews, 2016; 80: 629-661.

Choi U, Lee CR. Distinct roles of outer membrane porins in antibiotic resistance and membrane integrity in Escherichia coli. Front Microbiol, 2019; 10.

Xu T, Feng W, Sun F, Qian Y. Clinical and resistance characterization of Carbapenem-resistant Klebsiella pneumoniae isolated from intensive care units in China. Ann Transl Med, 2022; 10(20): 11.

Azar S, Ebadi A. Examining the pattern of susceptibility and antibiotic resistance in Klebsiella pneumoniae strains isolated from urine samples of children with urinary tract infections from the Children's Hospital of Tabriz in 2015. British Biomedical Bulletin, 2017; 5.

Naqid IA, Hussein NR, Balatay AA, Saeed KA, Ahmed HA. The antimicrobial resistance pattern of Klebsiella pneumoniae isolated from the clinical specimens in Duhok City in Kurdistan Region of Iraq. J Kermanshah Univ Med Sci, 2020; 24(2): e106135.

Kaur A, Wasan RK, Kaur C, Sethi P, Kaur V. Antibiotic resistance pattern of Klebsiella pneumoniae a major problem for society. International Journal of Health Sciences, 2022; 6(S2): 4699–4712.

Wulandhany AF, Pratiwi DIN, Muthmainah N, Biworo A. Susceptibility pattern of ESBL urine specimens in non-intensive care room at Ulin General Hospital. Indonesian Journal of Clinical Pathology and Medical Laboratory, 2021; 27(3): 254-259.

Jalal NA, Al-Ghamdi, AA, Aiman M. Momenah, Sami S. Prevalence and antibiogram pattern of Klebsiella pneumoniae in a tertiary care hospital in Makkah, Saudi Arabia: An 11-year experience. Antibiotics, 2023; 12: 164.

Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog Glob Health, 2015; 109(7): 309-18.

Virawan H, Nuryastuti T, Nirwati H. Multidrug-resistant Klebsiella pneumoniae from clinical isolates at dr. Soeradji Tirtonegoro Central Hospital Klaten. JKKI [Internet]. 2020; 11(2): 109-20. Available from: https://journal.uii.ac.id/JKKI/article/view/13455 (accessed July 31, 2023).

Abdul Raouf FE, Benyagoub E, Alkhudairy MK, Akrami S, Saki M. Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia. Rev Assoc Med Brass, 2022; 68(6): 833-837.

Mohammed AB, Anwar KA. Phenotypic and genotypic detection of extended spectrum beta lactamase enzyme in Klebsiella pneumoniae. PLoS One, 2022; 17(9): e0267221.

Cheddie P, Dziva F, Akpaka PE. Detection of a CTX-M group 2 beta-lactamase gene in a Klebsiella pneumoniae isolate from a tertiary care hospital, Trinidad and Tobago. Ann Clin Microbiol Antimicrob, 2017; 16: 33.

Shahraki S, Rostami FM, Feishani MH, Mohagheghifard AH, Jahani S, Majidiani H. Evaluation of Quinolone-resistant strains of Klebsiella pneumonia in clinical specimens obtained from patients reffered to Zahedan Educational Hospital. Res Med Sci, 2015; 17(8): e1022.

Khalid K, Lubián AF, Mac L, Lin RCY, Iredell JR. Characterizing the role of porin mutations in susceptibility of betalactamase producing Klebsiella pneumoniae isolates to Ceftaroline and Ceftaroline-Avibactam. International Journal of Infectious Diseases, 2020; 93: 252–257.

Jaber ZK, Al-Deresawi MS, Matrood AA. Mutation in Ompk35 are evolution pathway in antibiotic resistance. HIV Nursing, 2023; 23(1): 830-835.

Downloads

Submitted

2023-07-04

Accepted

2023-10-12

Published

2024-06-06

How to Cite

[1]
Hidayat, H., Parwati, I. and Srianto, E.A. 2024. Susceptibility Pattern, Genotyping, and Mutations of Klebsiella pneumoniae at Dr. H. Abdul Moeloek General Hospital. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 30, 3 (Jun. 2024), 238–244. DOI:https://doi.org/10.24293/ijcpml.v30i3.2206.

Issue

Section

Articles